Heliae Development and Syndel Laboratories Announce Distribution Agreement
ABO member Heliae today announced that it has signed an exclusive distribution agreement with Syndel Laboratories: Heliae will be supplying the aquaculture market with Nymega, a new DHA precision formulation ingredient for feed formulators.
As the global demand for fish increases, the aquaculture industry is on the rise. But the industry is increasingly facing sustainability challenges as it searches for new, reliable and affordable sources of omega-3 fatty acids to increase the content of DHA in farmed salmon. Heliae’s Nymega algae is DHA-rich and provides a precision tool for targeting DHA levels in feed.
As Len Smith, CBO at Heliae, explains: “Nymega’s simple profile allows formulators to target specific DHA content, providing key benefits across fish species and at multiple growth stages—at a price that is finally affordable.”
More details about the agreement and the product can be found in the press release.